Evidence map›Paper›PMID 31337617›Full record

ArticleCancer discovery2019

A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.

Richard L Bennett, Aditya Bele, Eliza C Small, Christine M Will, Behnam Nabet, Jon A Oyer, Xiaoxiao Huang, Rajarshi P Ghosh, Adrian T Grzybowski, Tao Yu and 8 more

Abstract read
In one paragraph

Article in Cancer discovery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Uterine carcinosarcoma: Unraveling the role of epithelial-to-mesenchymal transition in progression and therapeutic potential.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Richard L BennettDivision of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, Florida.
Aditya BeleDivision of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, Florida.
Eliza C SmallDivision of Hematology/Oncology, Northwestern University, Evanston, Illinois.
Christine M WillDivision of Hematology/Oncology, Northwestern University, Evanston, Illinois.
Behnam NabetDepartment of Cancer Biology, Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-6738-4200
Jon A OyerDivision of Hematology/Oncology, Northwestern University, Evanston, Illinois.
Xiaoxiao HuangDivision of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, Florida.
Rajarshi P GhoshDepartment of Bioengineering, Stanford University, Stanford, California.
Adrian T GrzybowskiDepartment of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, Illinois.
Tao YuDepartment of Chemistry, Tennessee Technological University, Cookeville, Tennessee.
Qiao ZhangDepartment of Chemical Engineering, University of Florida, Gainesville, Florida.
Alberto RivaBioinformatics Core, Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, Florida.ORCID 0000-0001-9150-8333
Tanmay P LeleDepartment of Chemical Engineering, University of Florida, Gainesville, Florida.
George C SchatzDepartment of Chemistry, Northwestern University, Evanston, Illinois.
Neil L KelleherDepartment of Chemistry, Northwestern University, Evanston, Illinois.
Alexander J RuthenburgDepartment of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, Illinois.
Jan LiphardtDepartment of Bioengineering, Stanford University, Stanford, California.
Jonathan D LichtDivision of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, Florida. jdlicht@ufl.edu.ORCID 0000-0002-3942-1369
Northwestern University · USUniversity of Florida · USUniversity of Florida Health · USStanford University · USUniversity of Chicago · USDana-Farber Cancer Institute · USTennessee Technological University · US

Funding

TR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6M
TRANS-NETWORK PROJECTSU54CA143869 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WANG, JI-PING · 2009 to 2013
$12.8M
Spatio-Temporal Organization of Chromatin and Information Transfer in CancerU54CA193419 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BACKMAN, VADIM · 2015 to 2020
$10.4M
SUBSTRATE RIGIDITY AND GENE EXPRESSION: Role of Nuclear TensionR01EB014869 · NIBIB · UNIVERSITY OF FLORIDA · PI LELE, TANMAY P. · 2012 to 2019
$3.4M
Quantitatively probing intra-nucleosomal chromatin variation and functionR01GM115945 · NIGMS · UNIVERSITY OF CHICAGO · PI RUTHENBURG, ALEXANDER JACKSON · 2016 to 2020
$1.6M
NCI NIH HHS U54 CA143869NCI NIH HHS U54 CA193419NIBIB NIH HHS R01 EB014869NIGMS NIH HHS P41 GM108569NIGMS NIH HHS R01 GM115945
6 · The paper itself

Abstract

By examination of the cancer genomics database, we identified a new set of mutations in core histones that frequently recur in cancer patient samples and are predicted to disrupt nucleosome stability. In support of this idea, we characterized a glutamate to lysine mutation of histone H2B at amino acid 76 (H2B-E76K), found particularly in bladder and head and neck cancers, that disrupts the interaction between H2B and H4. Although H2B-E76K forms dimers with H2A, it does not form stable histone octamers with H3 and H4

Indexed as

MutationOncogenesAllelesCell Line, TumorCell Transformation, NeoplasticGene ExpressionGene Expression ProfilingHistonesHumansMutation, MissenseNeoplasmsNucleosomesProtein MultimerizationYeastsHistonesNucleosomes

Identifiers

PMID31337617
PMCPMC6774836
OpenAlexW2963172415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.